| 25383-1 |
Cow milk Ab.IgE.RAST class |
PrThr |
Ser |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Cow milk IgE Ab RAST class [Presence] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
25383-1 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Cow Milk IgE RAST Ql |
|
|
|
|
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f002; f2; f43; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.75 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 25384-9 |
Coxiella burnetii Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Coxiella burnetii IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
25384-9 |
|
IF |
|
|
Both |
|
|
|
0 |
C burnet IgG Titr Ser IF |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Q fev; Q fever; Qfever; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 25385-6 |
Coxiella burnetii Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Coxiella burnetii IgM Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
25385-6 |
|
IF |
|
|
Both |
|
|
|
0 |
C burnet IgM Titr Ser IF |
|
|
|
Y |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; C burnet; C burnetii; Coxiella burnettii; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Q fev; Q fever; Qfever; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 25386-4 |
Creatinine |
SCnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
Creatinine [Moles/volume] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
mmol/L;umol/L |
|
|
|
|
|
|
CHEM |
|
25386-4 |
|
|
|
|
Both |
|
|
|
0 |
Creat Fld-sCnc |
|
|
|
Y |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; CR; Crea; Creat; Fl; Fld; FLU; Fluid; Kidney; Level; Nephrology; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Substance Concentration |
2.73 |
2 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 25387-2 |
Cyanide |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cyanide [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
25387-2 |
|
|
|
|
Both |
|
|
|
0 |
Cyanide SerPl-sCnc |
|
|
|
Y |
|
CN; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
2 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 25388-0 |
Cystathionine |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Cystathionine [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
25388-0 |
|
|
|
|
Observation |
|
|
|
0 |
Cystathionin 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Cystathioninie; Cysthanthionine; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.73 |
2 |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
| 25389-8 |
Taenia solium larva Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Taenia solium larva IgG Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
OD units |
|
|
|
|
|
|
MICRO |
|
25389-8 |
|
IA |
|
|
Both |
|
|
|
0 |
T sol lar IgG Ser IA-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cysticercosis; Cysticercus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS; T sol; T sol lar; T solium; Tapeworm |
2.73 |
2 |
|
|
|
|
|
|
|
{OD_unit} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 2539-5 |
Lactate dehydrogenase 2/Lactate dehydrogenase.total |
CFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
2539-5 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
LDH2 CFr SerPl Elph |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Fraction; Chemistry; Dehydrog; Dehyrdogenase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; II; L.D.H; Lact; Lactate dehydrogenase.fraction 2; Lactic acid; Lactic acid dehydrogenase; LD; LD2; LD-2; LDH; LDH isoenzyme 2; LDH2; L-lactate; L-lactate dehydrogenase; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl; Tumor marker |
2.73 |
1 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 25390-6 |
Cytokeratin 19 |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Cytokeratin 19 [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
25390-6 |
|
|
|
|
Both |
|
|
|
0 |
CK 19 SerPl-mCnc |
|
|
|
Y |
|
Autoimmune hepatitis; Chemistry; CK; CK 19; Cyfra 21-1; Keratin 19; Keratin, type I cytoskeletal 19; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 25391-4 |
Dehydroepiandrosterone |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Dehydroepiandrosterone (DHEA) [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
25391-4 |
|
|
|
|
Both |
|
|
|
0 |
DHEA 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; DHEA; Endocrine; Endocrinology; Prasterone; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
2 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
| 25392-2 |
Dengue virus Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Dengue virus IgM Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
25392-2 |
|
IB |
|
|
Both |
|
|
|
0 |
DENV IgM Ser Ql IB |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; Breakbone fever; Denv; Flavivirus; ID; IMMUNE BLOT; Immune globulin M; Immunobl; Immunoblot; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
2 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 25393-0 |
Desethylamiodarone |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Desethylamiodarone [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
25393-0 |
|
|
|
|
Both |
|
|
|
0 |
Desethylamiodarone SerPl-sCnc |
|
|
|
Y |
|
Amiodarone metabolite; DEA; DRUG/TOXICOLOGY; Drugs; Level; Noramiodarone; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.42 |
2 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 25394-8 |
Nortrimipramine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Nortrimipramine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
25394-8 |
|
|
|
|
Both |
|
|
|
0 |
Nortrimipramine SerPl-sCnc |
|
|
|
Y |
|
Addiction; Desmeth; Desmethyltrimipramine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trimipramine metabolite |
2.34 |
2 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 25395-5 |
Dog serum albumin Ab.IgE.RAST class |
PrThr |
Ser |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Dog serum albumin IgE Ab RAST class [Presence] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
25395-5 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Dog Serum Alb IgE RAST Ql |
|
|
|
Y |
|
a176; ABS; Aby; Alb; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Canine; e221; IgE RAST; Immune globulin E; Immunoglobulin E; nCan f 3; Ordinal; Point in time; PR; Protein.albumin; QL; Qual; Qualitative; Random; Re221; Screen; Ser; Serum; SR |
2.75 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 25396-3 |
Duck meat Ab.IgE.RAST class |
PrThr |
Ser |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Duck meat IgE Ab RAST class [Presence] in Serum |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
25396-3 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Duck Meat IgE RAST Ql |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f157; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.75 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 25397-1 |
Echinococcus sp Ab |
PrThr |
Ser |
Pt |
Ord |
IA |
|
ACTIVE |
Echinococcus sp Ab [Presence] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
25397-1 |
|
IA |
|
|
Both |
|
|
|
0 |
Echinococcus Ab Ser Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Echinococcosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; p2; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; SUDS |
2.73 |
2 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 25398-9 |
Echinococcus sp Ab |
ACnc |
Ser |
Pt |
Qn |
CIE |
|
ACTIVE |
Echinococcus sp Ab [Units/volume] in Serum by Counterimmunoelectrophoresis (CIE) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
25398-9 |
|
CIE |
|
|
Both |
|
|
|
0 |
Echinococcus Ab Ser CIE-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Counterimmunoelectrophoresis; Echinococcosis; ID; Infectious Disease; InfectiousDisease; Microbiology; p2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR |
2.69 |
2 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 25399-7 |
Endomysium Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Endomysium Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
25399-7 |
|
IF |
|
|
Both |
|
|
|
0 |
Endomysium Ab Titr Ser IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EMA; Endomysial; FA; Fluorescent antibody; Fluoresent; Gastro; Gastroenterology; GI; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; Transglutaminase; TRF; Ttr |
2.75 |
2 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 254-3 |
5-Fluorocytosine |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
5-Fluorocytosine [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
254-3 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
5-fluorocytosine Islt KB |
|
|
|
|
|
Alcobon; Ancobon; Ancotil; ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; Flucytosine; Fluorocytosin; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.21 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 2540-3 |
Lactate dehydrogenase 2 |
CCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lactate dehydrogenase 2 [Enzymatic activity/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2540-3 |
|
|
|
|
Observation |
|
|
|
0 |
LDH2 SerPl-cCnc |
|
|
|
Y |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Catalytic Concentration; Chemistry; Dehydrog; Dehyrdogenase; II; L.D.H; Lact; Lactate dehydrogenase.fraction 2; Lactic acid; Lactic acid dehydrogenase; LD; LD2; LD-2; LDH; LDH isoenzyme 2; LDH2; L-lactate; L-lactate dehydrogenase; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker |
2.73 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
| 25400-3 |
Entamoeba histolytica Ab |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
Entamoeba histolytica Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
25400-3 |
|
IF |
|
|
Both |
|
|
|
0 |
E histolyt Ab Titr Ser IF |
|
|
|
Y |
|
ABS; Aby; ACIF; Ameba; Amebiasis; Amebic; Amoeba; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); E histolyt; E histolytica; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 25401-1 |
Estradiol |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Estradiol (E2) [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
25401-1 |
|
|
|
|
Both |
|
|
|
0 |
Estradiol 24h Ur-sRate |
|
|
|
Y |
|
1 day; 17-beta estradiol; 24 hours; 24HR; Chemistry; E2; Gyn; Gynecology; OB; ObGyn; Obstetrics; Oestradiol; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
2 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
| 25402-9 |
Estrogen |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Estrogen [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
25402-9 |
|
|
|
|
Both |
|
|
|
0 |
Estrogen 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; Gyn; Gynecology; OB; ObGyn; Obstetrics; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.4 |
2 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
| 25403-7 |
Estrone |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Estrone (E1) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
25403-7 |
|
|
|
|
Both |
|
|
|
0 |
Estrone Ur-sCnc |
|
|
|
Y |
|
Chemistry; E1; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.42 |
2 |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 25404-5 |
Ethambutol |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Ethambutol [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
25404-5 |
|
|
|
|
Both |
|
|
|
0 |
Ethambutol SerPl Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Etambol; Ethamb; Inagen; Myambutol; Mycobutol; Olbutam; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
2 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
